Clinical study reports are not commercially confidential, says UK governmentBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6942 (Published 19 November 2013) Cite this as: BMJ 2013;347:f6942
- Zosia Kmietowicz
The government has said that clinical study reports, which hold vast amounts of information on the conduct, adverse events, and outcomes of a trial, should be made publicly available once a regulatory decision about a drug has been made.1
It was responding to a report from MPs on the House of Commons Science and Technology Committee on clinical trials, published in September.2 The MPs said that the United Kingdom had an “unacceptable” approach to clinical trials that allowed the results of too many studies to remain unseen by clinicians, scientists, and the public and that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial